1. Home
  2. SUNS vs ELDN Comparison

SUNS vs ELDN Comparison

Compare SUNS & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUNS
  • ELDN
  • Stock Information
  • Founded
  • SUNS 2023
  • ELDN 2004
  • Country
  • SUNS United States
  • ELDN United States
  • Employees
  • SUNS N/A
  • ELDN 31
  • Industry
  • SUNS Real Estate Investment Trusts
  • ELDN Biotechnology: Pharmaceutical Preparations
  • Sector
  • SUNS Real Estate
  • ELDN Health Care
  • Exchange
  • SUNS Nasdaq
  • ELDN Nasdaq
  • Market Cap
  • SUNS 148.2M
  • ELDN 176.1M
  • IPO Year
  • SUNS N/A
  • ELDN N/A
  • Fundamental
  • Price
  • SUNS $9.06
  • ELDN $2.99
  • Analyst Decision
  • SUNS Strong Buy
  • ELDN Strong Buy
  • Analyst Count
  • SUNS 3
  • ELDN 1
  • Target Price
  • SUNS $13.42
  • ELDN $16.00
  • AVG Volume (30 Days)
  • SUNS 165.4K
  • ELDN 249.0K
  • Earning Date
  • SUNS 05-07-2025
  • ELDN 05-08-2025
  • Dividend Yield
  • SUNS 10.23%
  • ELDN N/A
  • EPS Growth
  • SUNS N/A
  • ELDN N/A
  • EPS
  • SUNS 1.00
  • ELDN N/A
  • Revenue
  • SUNS $10,588,270.00
  • ELDN N/A
  • Revenue This Year
  • SUNS $141.80
  • ELDN N/A
  • Revenue Next Year
  • SUNS $53.98
  • ELDN N/A
  • P/E Ratio
  • SUNS $9.06
  • ELDN N/A
  • Revenue Growth
  • SUNS 1342.10
  • ELDN N/A
  • 52 Week Low
  • SUNS $7.80
  • ELDN $1.55
  • 52 Week High
  • SUNS $15.74
  • ELDN $5.54
  • Technical
  • Relative Strength Index (RSI)
  • SUNS N/A
  • ELDN 39.03
  • Support Level
  • SUNS N/A
  • ELDN $2.63
  • Resistance Level
  • SUNS N/A
  • ELDN $3.21
  • Average True Range (ATR)
  • SUNS 0.00
  • ELDN 0.24
  • MACD
  • SUNS 0.00
  • ELDN 0.03
  • Stochastic Oscillator
  • SUNS 0.00
  • ELDN 45.24

About SUNS Sunrise Realty Trust Inc. Common Stock

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: